News + Filings Holdings
All
13F
13D/G
Other
|
|
Meditor Group Ltd
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/04/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/12/2022 |
SC 13G/A
| Meditor Group Ltd reports a 7.1% stake in Esperion Therapeutics, Inc. |
| 01/06/2021 |
SC 13G/A
| Meditor Group Ltd reports a 9.6% stake in Esperion Therapeutics, Inc. |
| 01/06/2020 |
SC 13G/A
| Meditor Group Ltd reports a 9.9% stake in Esperion Therapeutics, Inc. |
| 04/09/2019 |
SC 13G/A
| Meditor Group Ltd reports a 5% stake in Exelixis, Inc. |
| 01/03/2019 |
SC 13G/A
| Meditor Group Ltd reports a 9.9% stake in Esperion Therapeutics, Inc. |
| 01/02/2019 |
SC 13G/A
| Meditor Group Ltd reports a 5.3% stake in Exelixis, Inc. |
| 01/04/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/04/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/01/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/25/2013 |
SC 13G/A
| Meditor Group Ltd reports a 6.5% stake in Exelixis, Inc. |
| 08/17/2012 |
SC 13G/A
| Meditor Group Ltd reports a 5.1% stake in Vivus, Inc. |
| 07/26/2012 |
SC 13G/A
| Meditor Group Ltd reports a 4.6% stake in Vivus, Inc. |
| 07/26/2012 |
SC 13G/A
| Meditor Group Ltd reports a 5.8% stake in Vivus, Inc. |
| 05/03/2012 |
SC 13G/A
| Meditor Group Ltd reports a 4.7% stake in Vivus, Inc. |
| 03/21/2012 |
SC 13G/A
| Meditor Group Ltd reports a 6.3% stake in Vivus, Inc. |
|
|